BJDX
Income statement / Annual
Last year (2023), Bluejay Diagnostics, Inc.'s total revenue was $0.00,
a decrease of 100.00% from the previous year.
In 2023, Bluejay Diagnostics, Inc.'s net income was -$9.95 M.
See Bluejay Diagnostics, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00 |
$249,040.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$780,955.00
|
$200,129.00
|
$145,719.00
|
$157,039.00
|
$142,975.00
|
| Gross Profit |
-$780,955.00
|
$48,911.00
|
-$145,719.00
|
-$157,039.00
|
-$142,975.00
|
| Gross Profit Ratio |
0
|
0.2
|
0
|
0
|
0
|
| Research and Development Expenses |
$5.71 M
|
$4.15 M
|
$1.15 M
|
$527,253.00
|
$454,610.00
|
| General & Administrative Expenses |
$4.31 M
|
$4.76 M
|
$1.79 M
|
$596,116.00
|
$883,999.00
|
| Selling & Marketing Expenses |
$283,443.00
|
$451,421.00
|
$289,726.00
|
$73,022.00
|
$292,804.00
|
| Selling, General & Administrative Expenses |
$4.60 M
|
$5.21 M
|
$2.08 M
|
$669,138.00
|
$1.18 M
|
| Other Expenses |
$0.00
|
$258,137.00
|
-$75,000.00
|
$5,537.00
|
$749,445.00
|
| Operating Expenses |
$10.31 M
|
$9.37 M
|
$3.16 M
|
$1.20 M
|
$1.63 M
|
| Cost And Expenses |
$10.31 M
|
$9.57 M
|
$3.16 M
|
$1.20 M
|
$1.63 M
|
| Interest Income |
$164,900.00
|
$89,673.00
|
$513,296.00
|
$143,667.00
|
$52,284.00
|
| Interest Expense |
$0.00
|
$0.00
|
$367,459.00
|
$26,997.00
|
$0.00
|
| Depreciation & Amortization |
$780,955.00
|
$306,368.00
|
$145,719.00
|
$157,039.00
|
$142,975.00
|
| EBITDA |
-$9.17 M |
-$8.99 M |
-$3.08 M |
-$1.04 M |
-$1.49 M |
| EBITDA Ratio |
0
|
-36.38
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
-37.41
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$357,328.00
|
$20,828.00
|
-$258,135.00
|
$38,106.00
|
$811,571.00
|
| Income Before Tax |
-$9.95 M
|
-$9.30 M
|
-$3.49 M
|
-$1.16 M
|
-$819,842.00
|
| Income Before Tax Ratio |
0
|
-37.33
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
-$69,059.00
|
$241,388.00
|
-$32,569.00
|
-$62,126.00
|
| Net Income |
-$9.95 M
|
-$9.23 M
|
-$3.73 M
|
-$1.13 M
|
-$757,716.00
|
| Net Income Ratio |
0
|
-37.05
|
0
|
0
|
0
|
| EPS |
-72.62 |
-73.22 |
-29.67 |
-14.19 |
-9.55 |
| EPS Diluted |
-72.62 |
-73.22 |
-29.67 |
-14.19 |
-9.55 |
| Weighted Average Shares Out |
$137,062.00
|
$126,024.00
|
$125,701.00
|
$79,339.00
|
$79,339.00
|
| Weighted Average Shares Out Diluted |
$137,063.00
|
$126,024.00
|
$125,701.00
|
$79,339.00
|
$79,339.00
|
| Link |
|
|
|
|
|
